Lower cost doesn’t mean lower quality! We take pride in our industry-leading quality.
Passionate global team
We touch lives. That’s a powerful reason to come to work. Join us.
Patient community connections
Advocacy. Research. Awareness. We stand with the Parkinson’s community.
Focus on affordability 270+ medicines you need at costs you can afford.
Quality leader Lower cost doesn’t mean lower quality! We take pride in our industry-leading quality.
Passionate global team We touch lives. That’s a powerful reason to come to work. Join us.
Patient community connections Advocacy. Research. Awareness. We stand with the Parkinson’s community.
We make healthy possible®
Leading forward
Our leaders talk about how Amneal has diversified beyond generics to deliver value in complex retail generics, biosimilars, injectables, specialty and international.
As of March 1, 2024, Amneal has three reportable business segments: 1) Generics (includes retail, injectables, biosimilars & international revenue), 2) Specialty and 3) AvKARE (includes distribution, government label and institutional revenue).
Our products
Our broad portfolio of approximately 270+ generic and specialty pharmaceuticals is the foundation from which we make healthy possible. And we expanded our portfolios to institutions, in biosimilars and across select international markets.